• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子在肝细胞癌发生发展及淋巴结转移中的作用。

Role of the transcription factor in hepatocellular carcinoma development and lymph node metastasis.

作者信息

Teng Xiong, Li Tian-Man, Peng Kai, Li Yu-Hua, Zhang Han-Jing, Ge Bin, Xie Hai-Xiang, Yang Ke-Jian, Qin Chong-Jiu, Liao Xi-Wen, Zhu Guang-Zhi, Zhou Xin, Peng Tao

机构信息

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China.

出版信息

Transl Cancer Res. 2025 Aug 31;14(8):4882-4905. doi: 10.21037/tcr-2025-94. Epub 2025 Aug 27.

DOI:10.21037/tcr-2025-94
PMID:40950665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12432789/
Abstract

BACKGROUND

Lymph node metastasis (LNM) is one of the forms of hepatocellular carcinoma (HCC) dissemination, a phenomenon that is strongly correlated with an adverse prognosis. The transcription factor has been implicated in tumor progression in other malignancies, but its prognostic significance and mechanistic role in HCC LNM remain unexplored. This study aims to explore the prognostic significance and mechanistic role of the transcription factor in HCC LNM.

METHODS

We retrospectively enrolled 387 HCC patients who underwent radical hepatectomy with lymph-node dissection between 2013 and 2021, among whom 57 were LNM-positive and the remaining 330 were negative. Recurrence-free survival (RFS) and overall survival (OS) were estimated using Kaplan-Meier curves and compared by log-rank test; independent prognostic factors were identified with Cox proportional-hazards regression. mRNA levels in matched primary tumors and metastatic lymph nodes were quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Functional impacts of knockdown and overexpression were assessed in HCC cell lines via proliferation, migration, and invasion assays. Changes in epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, Vimentin) were examined by Western blot.

RESULTS

LNM, microvascular invasion (MVI), and the China Liver Cancer (CNLC) stage emerged as independent predictors of both shorter RFS and OS in the matched cohort; metastatic lymph nodes exhibited a 3.8-fold increase in mRNA compared to primary tumors (P<0.001). , knockdown significantly inhibited HCC cell proliferation, migration, and invasion, whereas overexpression produced the opposite effects. At the molecular level, modulation altered EMT marker expression-specifically, overexpression reduced E-cadherin while upregulating N-cadherin and Vimentin-demonstrating that drives EMT to promote HCC cell invasiveness and metastatic potential.

CONCLUSIONS

In summation, this study established a correlation between LNM and diminished RFS and OS among HCC patients. Moreover, it demonstrated the significant role of in HCC progression and LNM, which appears to modulate the malignant phenotype of HCC cells, encompassing enhanced proliferation, stem cell-like properties, and invasive migration through the induction of EMT. These collective findings implicate as a promising candidate for targeted therapeutic intervention in HCC.

摘要

背景

淋巴结转移(LNM)是肝细胞癌(HCC)播散的形式之一,这一现象与不良预后密切相关。转录因子 在其他恶性肿瘤的肿瘤进展中发挥作用,但其在HCC-LNM中的预后意义和机制作用仍未得到探索。本研究旨在探讨转录因子 在HCC-LNM中的预后意义和机制作用。

方法

我们回顾性纳入了2013年至2021年间接受根治性肝切除术并进行淋巴结清扫的387例HCC患者,其中57例LNM阳性,其余330例为阴性。采用Kaplan-Meier曲线估计无复发生存期(RFS)和总生存期(OS),并通过对数秩检验进行比较;通过Cox比例风险回归确定独立预后因素。通过逆转录定量聚合酶链反应(RT-qPCR)对配对的原发性肿瘤和转移性淋巴结中的 mRNA水平进行定量。通过增殖、迁移和侵袭试验评估 敲低和过表达对HCC细胞系的功能影响。通过蛋白质免疫印迹法检测上皮-间质转化(EMT)标志物(E-钙黏蛋白、N-钙黏蛋白、波形蛋白)的变化。

结果

在配对队列中,LNM、微血管侵犯(MVI)和中国肝癌(CNLC)分期是RFS和OS缩短的独立预测因素;与原发性肿瘤相比,转移性淋巴结中的 mRNA增加了3.8倍(P<0.001)。 敲低显著抑制HCC细胞增殖、迁移和侵袭,而过表达则产生相反的效果。在分子水平上, 调节改变了EMT标志物的表达,具体而言, 过表达降低了E-钙黏蛋白,同时上调了N-钙黏蛋白和波形蛋白,表明 通过驱动EMT促进HCC细胞的侵袭性和转移潜能。

结论

总之,本研究建立了HCC患者中LNM与RFS和OS降低之间的相关性。此外,它证明了 在HCC进展和LNM中的重要作用,其似乎通过诱导EMT调节HCC细胞的恶性表型,包括增强增殖、干细胞样特性和侵袭性迁移。这些共同发现表明 是HCC靶向治疗干预的有希望候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/ec768048309d/tcr-14-08-4882-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/62745cebf6f4/tcr-14-08-4882-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/8ea4b3586e8a/tcr-14-08-4882-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/8f19914bcd0f/tcr-14-08-4882-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/a6d42f2877b4/tcr-14-08-4882-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/f97b19b32c2d/tcr-14-08-4882-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/878219ccaf0f/tcr-14-08-4882-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/7b2731c84d4c/tcr-14-08-4882-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/9ffc83b64ef3/tcr-14-08-4882-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/48e643bd4000/tcr-14-08-4882-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/3be27f762f36/tcr-14-08-4882-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/ec768048309d/tcr-14-08-4882-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/62745cebf6f4/tcr-14-08-4882-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/8ea4b3586e8a/tcr-14-08-4882-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/8f19914bcd0f/tcr-14-08-4882-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/a6d42f2877b4/tcr-14-08-4882-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/f97b19b32c2d/tcr-14-08-4882-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/878219ccaf0f/tcr-14-08-4882-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/7b2731c84d4c/tcr-14-08-4882-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/9ffc83b64ef3/tcr-14-08-4882-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/48e643bd4000/tcr-14-08-4882-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/3be27f762f36/tcr-14-08-4882-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/12432789/ec768048309d/tcr-14-08-4882-f11.jpg

相似文献

1
Role of the transcription factor in hepatocellular carcinoma development and lymph node metastasis.转录因子在肝细胞癌发生发展及淋巴结转移中的作用。
Transl Cancer Res. 2025 Aug 31;14(8):4882-4905. doi: 10.21037/tcr-2025-94. Epub 2025 Aug 27.
2
S100a4 promotes metastatic transformation in non-metastatic liver cancer cells through NMIIa binding: mechanistic insights.S100a4通过与NMIIa结合促进非转移性肝癌细胞的转移转化:机制洞察
BMC Cancer. 2025 Jul 4;25(1):1144. doi: 10.1186/s12885-025-14502-4.
3
Prognostic comparison between LNM and MaVI of hepatocellular carcinoma: a multicenter population-based propensity scores matching study.肝细胞癌淋巴结转移与微血管侵犯的预后比较:一项基于多中心人群的倾向评分匹配研究
BMC Gastroenterol. 2025 Aug 26;25(1):618. doi: 10.1186/s12876-025-03639-y.
4
[CENPI promotes the migration of liver cancer cells and the epithelial-mesenchymal transition process by activating the RAS/MEK/ERK signaling axis].CENPI通过激活RAS/MEK/ERK信号轴促进肝癌细胞的迁移和上皮-间质转化过程
Zhonghua Gan Zang Bing Za Zhi. 2025 Jul 20;33(7):674-682. doi: 10.3760/cma.j.cn501113-20231110-00189.
5
Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.再生肝磷酸酶-3在浸润性乳腺癌中的预后及转移价值
J Cancer Res Clin Oncol. 2010 Sep;136(9):1349-57. doi: 10.1007/s00432-010-0786-y. Epub 2010 Feb 6.
6
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
7
The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.环状RNA ciRS-7(Cdr1as)是肝细胞癌肝微血管侵犯的一个危险因素。
J Cancer Res Clin Oncol. 2017 Jan;143(1):17-27. doi: 10.1007/s00432-016-2256-7. Epub 2016 Sep 10.
8
High mobility group protein N2 inhibits the progression of hepatocellular carcinoma and the related molecular mechanisms.高迁移率族蛋白N2抑制肝细胞癌进展及相关分子机制
Cytotechnology. 2025 Feb;77(1):20. doi: 10.1007/s10616-024-00678-3. Epub 2024 Dec 12.
9
Correlation between clinical and pathological nodal status in hepatocellular carcinoma: identifying risk factors for lymph node metastasis via the national cancer database.肝细胞癌临床与病理淋巴结状态的相关性:通过国家癌症数据库确定淋巴结转移的危险因素
World J Surg Oncol. 2025 Aug 12;23(1):311. doi: 10.1186/s12957-025-03950-8.
10
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).一线化疗免疫治疗联合或不联合放疗对局部晚期或转移性食管鳞状细胞癌患者预后的影响:一项来自中国的多中心、真实世界、回顾性队列研究(NCT06478355)
Front Immunol. 2025 Jul 28;16:1633930. doi: 10.3389/fimmu.2025.1633930. eCollection 2025.

本文引用的文献

1
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.肝细胞癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2025 May;36(5):491-506. doi: 10.1016/j.annonc.2025.02.006. Epub 2025 Feb 20.
2
The Role of Lymphadenectomy in the Surgical Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.淋巴结清扫术在肝细胞癌外科治疗中的作用:一项系统评价和荟萃分析
Cancers (Basel). 2024 Dec 13;16(24):4166. doi: 10.3390/cancers16244166.
3
SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.
SOX12 通过促进调节性 T 细胞浸润和免疫抑制促进肝细胞癌的进展和转移。
Adv Sci (Weinh). 2024 Sep;11(36):e2310304. doi: 10.1002/advs.202310304. Epub 2024 Jul 29.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.TGF-β1 诱导的 SOX18 升高通过转录上调 PD-L1 和 CXCL12 促进肝细胞癌的进展和转移。
Gastroenterology. 2024 Jul;167(2):264-280. doi: 10.1053/j.gastro.2024.02.025. Epub 2024 Feb 27.
6
Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry.在肝外科的现代时代,对胆管癌、肝细胞癌和结直肠癌肝转移进行淋巴结切除术的短期术后结果:来自 StuDoQ|Liver 登记处的见解。
Eur J Surg Oncol. 2024 Apr;50(4):108010. doi: 10.1016/j.ejso.2024.108010. Epub 2024 Feb 8.
7
S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.S100A6 通过激活 RAGE/NF-kB/VEGF-D 通路促进肝癌淋巴转移。
Cancer Lett. 2024 Apr 10;587:216709. doi: 10.1016/j.canlet.2024.216709. Epub 2024 Feb 11.
8
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
9
Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis.SOX8 过度表达重新编程能量和铁代谢,使肝癌对铁死亡敏感。
Redox Biol. 2024 Feb;69:103002. doi: 10.1016/j.redox.2023.103002. Epub 2023 Dec 17.
10
Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma.局部治疗在肝细胞癌淋巴结转移中的疗效
Liver Cancer. 2023 Jan 18;12(3):218-228. doi: 10.1159/000529201. eCollection 2023 Aug.